Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis

Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

(2020) Elias S. Sotirchos et al.   ANNALS OF NEUROLOGY

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

(2018) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort

(2017) Kimberly M Winges et al.   Multiple Sclerosis Journal

Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort

(2017) Kimberly M Winges et al.   Multiple Sclerosis Journal

The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane’s Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats

(2016) Daniel Ruiz-Pérez et al.   ANESTHESIA AND ANALGESIA

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis

(2016) Robert J. Fox et al.   Contemporary Clinical Trials

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

(2015) Shiv Saidha et al.   ANNALS OF NEUROLOGY

Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives

(2015) Daniel Ontaneda et al.   LANCET NEUROLOGY

Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning

(2012) J. N. Ratchford et al.   NEUROLOGY

The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment

(2012) Prejaas Tewarie et al.   PLoS One

Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials

(2011) John L. Keltner et al.   NEURO-OPHTHALMOLOGY

The Impact of Utilizing Different Optical Coherence Tomography Devices for Clinical Purposes and in Multiple Sclerosis Trials

(2011) Christina V. Warner et al.   PLoS One

Reproducibility of high-resolution optical coherence tomography in multiple sclerosis

(2010) Stephanie B Syc et al.   Multiple Sclerosis Journal

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast

(2010) Y. Cho et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cross-species comparisons of the pharmacokinetics of ibudilast

(2009) L. M. Sanftner et al.   XENOBIOTICA